Authors
Loading...
Longitudinal cohort study uncovers gut dysbiosis and molecular disruptions during active inflammatory bowel disease, highlighting key microbial and metabolic drivers of inflammation.
Lloyd‐Price et al. (2019) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: